Browse by Poster Presenter

Skip to main content

ICPE 2023 Main banner

ICPE 2023 Program

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

P
Pak, Joyce

University of North Carolina Chapel Hill
(082) Visualizing Discrepancies Between a Body of Trials and a Real-World Population: An Example from the COVID-19 Pandemic
Joyce Pak
Favorite
(105) Describing Adjuvant Chemotherapy Delivery in Older and Younger Women with Early-Stage Breast Cancer Using Longitudinal Cumulative Dose
Joyce Pak
Favorite
Palmer, Liisa

Merative
(A08) Using Real-World Data to Support Clinical Trial Diversity and Inclusion Strategies: A Case Study of Cancer of the Cervix
Liisa Palmer
Favorite
Palmsten, Kristin

Pregnancy and Child Health Research Center, HealthPartners Institute
(127) Antidepressant and Psychotherapy Initiation Among Patients with New Episodes of Depression During Pregnancy
Kristin Palmsten
Favorite
Panozzo, Catherine A.

Moderna, Inc.
(277) RSV Outcomes Study Extension (ROSE): Epidemiological and Operational Considerations for an Observational Study Linking Real-World Data through Tokenization to the mRNA-1345 RSV Vaccine Phase 3 Clinical Trial Data in Adults
Catherine A. Panozzo
Favorite
Pantuzza, Laís

Department of Management and Incorporation of Technologies in Health (DGITS)/Ministry of Health (MH)
(025) Monitoring biological treatments for psoriasis in the Brazilian Public Health System: a real-world study
Laís Pantuzza
Favorite
Park, Changwe

Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, KY, USA
(011) Assessment of Buprenorphine Dispensing in Texas Following the 2016 Federal-Level Buprenorphine Access Expansion Policies
Changwe Park
Favorite
Park, Chanhyun

Health Outcomes Division, College of Pharmacy, The University of Texas at Austin
(141) Comorbidity clusters before and after adjuvant endocrine therapy in oldest-old women with breast cancer: An unsupervised machine learning approach
Chanhyun Park
Favorite
Park, Haesuk

Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
(188) Nationwide trends in hospitalization, medical costs, and mortality for asthma after introduction of biologics: a cross-sectional study in the United States
Haesuk Park
Favorite
Park, Suvin

Ewha Womans University
(269) Association between simultaneous vaccination with live and inactivated vaccines and risk of hospitalization for non-vaccine-targeted infections
Suvin Park
Favorite
Park, Yoonyoung

Moderna, Inc.
(062) Factors Associated With Influenza and COVID-19 Vaccination in Older Adults
Yoonyoung Park
Favorite
Parzynski, Craig

Genesis Research, LLC
(046) An evaluation of commonly available imputation methods useful for RWE research
Craig Parzynski
Favorite
Pastula, Susan

EpidStrategies
(191) Respiratory Syncytial Virus (RSV) and Bronchiolitis Epidemiology Among the United States Infant Medicaid Populations in Seven States
Susan Pastula
Favorite
(192) The Burden of RSV and Bronchiolitis in the US Infant Medicaid Population Extends Beyond the Inpatient Setting
Susan Pastula
Favorite
Patel, Deesha

Aetion, Inc.
(081) Active surveillance and evaluation of anosmia/ageusia following mRNA-1273 administration: Learnings from a US administrative claims database study
Deesha Patel
Favorite
Patel, Kaushal

Industry
(142) Focus on types of risk minimization measures for carditis, associated with COVID-19 vaccines- FAERS Database Analysis
Kaushal Patel
Favorite
Paudel, Sabita

Gandaki Medical College
(198) Qualitative Assessment on Access to Treatment and Perceived Challenges Among Asthma Patients in a Hill Village of Nepal
Sabita Paudel
Favorite
Paulus, Jessica

OM1, Inc.
(191) The Association Between Credit Risk Score and Major Depressive Disorder Burden Using Observed and Estimated PHQ-9 in a Real-World Cohort
Jessica Paulus
Favorite
(222) Defining Provider Prescribing Preference as an Instrumental Variable: A Case Study of NOACs in Stroke Prevention
Jessica Paulus
Favorite
(235) Characterizing Disease Progression in Multiple Sclerosis Subtypes Using RWD: Feasibility of Applying a Machine Learning Model to Address Missing Data
Jessica Paulus
Favorite
(A44) Lessons Learned from the Development of Machine Learning Models to Estimate Validated Measures Using Real-World Data for Four Chronic Conditions
Jessica Paulus
Favorite
(C12) Identification of Treatment-Resistant Major Depressive Disorder using a Machine Learning Algorithm
Jessica Paulus
Favorite
Pawar, Mansi

Manipal College of Pharmaceutical Sciences
(073) Purine antimetabolites associated pneumocystis jiroveci pneumonia among autoimmune and cancer population
Mansi Pawar
Favorite
Perez-Vilar, Silvia

US Food and Drug Administration
(025) Expanding Capabilities for Unapproved Cannabis-Derived Product Surveillance in the United States, TriNetX, July 1, 2018 – June 30, 2022
Silvia Perez-Vilar
Favorite
(032) Exploring the Use of Electronic Health Records (EHR) Data for Active Safety Surveillance of Epidiolex in PCORnet, July 1, 2018- July 1, 2022
Silvia Perez-Vilar
Favorite
Perhanidis, Jessica

GSK, Waltham, MA, USA
(253) An Emulated Target Trial Case Study of Real-World Overall Survival in Second-line Maintenance Niraparib vs Active Surveillance in Patients with Recurrent Ovarian Cancer
Jessica Perhanidis
Favorite
Persson, Rebecca

Boston Collaborative Drug Surveillance Program
(046) Extent of apremilast exposure misclassification in CPRD Aurum: a validation study
Rebecca Persson
Favorite
Peymani, Payam

The University of Manitoba
(084) Patterns of antiseizure medications prescriptions among pregnant people with epilepsy: a utilization study in three Canadian provinces
Payam Peymani
Favorite
(117) Disparities in prescriptions medications use by socioeconomic status and geographical location during COVID-19 pandemic
Payam Peymani
Favorite
Pillay, Chriselda

University of Cape Town
(287) A Cross-Sectional Evaluation of Anticoagulation Control in Patients Receiving Warfarin in Nine African Countries
Chriselda Pillay
Favorite
Pineda-Moncusí, Marta

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
(A03) Ethnicity differences in risk of cardiovascular events in COVID-19: an England-wide population analysis
Marta Pineda-Moncusí
Favorite
Plaku, Bora

Optum LS Epidemiology
(159) Use of US Health Insurance Claims Data to Determine Cause of Death
Bora Plaku
Favorite
Plebon-Huff, Sieara

Health Canada
(043) Health Canada’s Vigilance Framework for Cannabis: A summary of adverse reactions associated with cannabis products
Sieara Plebon-Huff
Favorite
Ponder, Madison

University of North Carolina at Chapel Hill
(094) Plans Change: A Competing Risks Analysis of Time to Unplanned Stopping of Long-Term Outpatient Antibiotic Treatment, 2015-2022
Madison Ponder
Favorite
Pont, Lisa

Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia
(022) Temporal Trends in Adverse Drug Reactions Reports of Medicines for Treating Human Immunodeficiency Virus and Tuberculosis, and All Diseases: Joinpoint Regression
Lisa Pont
Favorite
(023) Validity of the ISMP Medication Safety Self-Assessment® for Long-Term Care tool in Australian nursing homes
Lisa Pont
Favorite
(C11) Effect of Mobile Applications on the Spontaneous Reporting of Adverse Drug Reactions: A Systematic Review and Individual Patient Data Meta-Analysis
Lisa Pont
Favorite
Poojari, Pooja Gopal

Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education,Manipal
(047) Technology Aided Intervention to Improve the Metabolic Monitoring Rate in Patients on Atypical Antipsychotics
Pooja Gopal Poojari
Favorite
Popoola, Victor

Regeneron Pharmaceuticals
(139) Background Rates of Pediatric-Onset Type I Diabetes Before and During the COVID-19 Pandemic
Victor Popoola
Favorite
Ports, Kayleen

Medidata AI, a Dassault Systèmes Company, New York
(132) Validated Algorithms to Identify Non-fatal Strokes using Uniform Objective Criteria: A Pooled Clinical Trial Data Analysis
Kayleen Ports
Favorite
Pottegård, Anton

Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark.
(039) Describing medication changes near end-of-life: Applied example and methodological considerations
Anton Pottegård
Favorite
(143) Polypharmacy's association to mortality: A methodological case study
Anton Pottegård
Favorite
(214) Validation of Indication for Use (INDO) in the Danish National Prescription Registry
Anton Pottegård
Favorite
Pradhan, Pallavi

University of Quebec at Trois-Rivieres (UQTR)
(063) Causality assessment of adverse drug reactions in post-authorization settings: An analysis from four different countries to find out the most comprehensive and easy-to-use tool
Pallavi Pradhan
Favorite
Pradhan, Richeek

Harvard Medical School and Brigham and Women's Hospital
(B35) Glucagon Like Peptide-1 Receptor Agonists and the Risk of Skin Cancer Among Patients with Type 2 Diabetes: Population-Based Cohort Study
Richeek Pradhan
Favorite
Praet, Nicolas

The Janssen Pharmaceutical Companies of Johnson & Johnson
(025) Quantitative benefit-risk assessment of vaccination against COVID-19: a systematic literature review
Nicolas Praet
Favorite
Prats-Uribe, Albert

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
(014) Use of intra-articular corticosteroid injections among osteoarthritis patients in UK general practice
Albert Prats-Uribe
Favorite
Preethi, Chunduri

National Institute of Pharmaceutical Education and Research Guwahati
(200) Assessment of Potential Risk Factors and Biochemical Predictors for the Interstitial Lung Disease in Patients with Rheumatoid Arthritis
Chunduri Preethi
Favorite
Pritchard, David

Target RWE
(260) Characterizing the Distribution of Multiple Negative Control Outcome Risk Differences
David Pritchard
Favorite
Probst, Jessica

OM1 Inc.
(204) The Association Between Social Determinants of Health and 1-Year Survival Among Patients with Heart Failure in a Real-World Cohort
Jessica Probst
Favorite
PS, Haripriya

Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham
(183) To Estimate the Frequency of Brain Metastases, Presentation of Metastases, Location, Treatment Pattern and paradigm changes in the Brain Metastases Management Among the Population of Southern Asia
Haripriya PS
Favorite
(245) Efficacy of Hippocampal Avoidance Whole Brain Radiation Therapy in Preventing Neurocognitive Dysfunction Induced by Radiation Therapy in Patients with Brain Metastases: A Systematic Review and Meta-Analysis
Haripriya PS
Favorite